CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Institute of Hematology & Blood Diseases Hospital, China
Nantes University Hospital
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Comenius University
Centre Hospitalier Universitaire de Nice
Washington University School of Medicine
University of Miami
Dana-Farber Cancer Institute
St. Justine's Hospital
University of Arizona
Assiut University
Mayo Clinic
Institute of Hematology & Blood Diseases Hospital, China
Children's Oncology Group
University of Alabama at Birmingham